EZET — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-14

• The Fund is an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act (the “JOBS Act”), subject to reduced public company reporting requirements under U.S. federal securities laws.

• For the three months ended June 30, 2026, 150,000 Shares were issued in exchange for 1,137.1708 ether and 100,000 Shares were redeemed in exchange for 758.1693 ether. The Fund’s NAV per Share began the period at $15.94 and ended the period at $12.07. The 24.28% decrease in the Fund's NAV from $15.94…

• Net realized and change in unrealized loss on investment in ether for the three months ended June 30, 2026, was approximately $10,608,420 which includes a net realized loss from ether sold for the redemption of shares and sold to pay expenses of $945,762 and net change in unrealized depreciation on …

• For the quarter ended June 30, 2025, 450,000 Shares were issued in exchange for 3,417.9518 ether and 150,000 Shares were redeemed in exchange for 1,145.1553 ether. The Fund’s NAV per Share began the period at $13.94 and ended the period at $18.99. The 36.23% increase in the Fund's NAV from $13.94 at…

• Net realized and change in unrealized gain on investment in ether for the quarter ended June 30, 2025 was approximately $7,200,320, which includes a net realized loss on investment in ether sold for redemptions of $1,744,386 and net change in unrealized appreciation on investment in ether of approxi…

Text removed vs the prior filing · source: 10-Q · 2026-02-17

• For a period from July 23, 2024 (the day the Shares were initially listed on the Exchange) to January 31, 2025, the Sponsor agreed to waive the entire Sponsor’s Fee on the first $10.0 billion of the Fund’s assets. In the future, if the Sponsor decides to waive all or a portion of the Sponsor’s Fee, …

• The Fund is an “emerging growth company” as that term is used in the Securities Act of 1933, as amended (the “Securities Act”), and, as such, the Fund may elect to comply with certain reduced public company reporting requirements.

• Results of Operations for the quarter ended December 31, 2025

• For the three months ended to December 31, 2025, 450,000 Shares were issued in exchange for 3,415.0200 ether and 800,000 Shares were redeemed in exchange for 6,070.5184 ether. The Fund’s NAV per Share began the period at $31.35 and ended the period at $22.54. The 28.10% decrease in the Fund's NAV fr…

• Net realized and change in unrealized loss on investment in ether for the three months ended December 31, 2025, was approximately $24,485,232 which includes a net realized gain on investment in ether sold for redemptions of $353,054 and net change in unrealized depreciation on investment in ether of…

Text added vs the prior filing · source: 10-Q · 2026-08-14

• Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

• Under the supervision and with the participation of the Principal Executive Officer and Principal Financial Officer of the Sponsor, the Sponsor conducted an evaluation of the Trust’s disclosure controls and procedures, as defined under Exchange Act Rule 13a-15(e) as of June 30, 2026 and concluded th…

• Under the supervision and with the participation of the Principal Executive Officer and Principal Financial Officer of the Sponsor, the Sponsor conducted an evaluation of the Trust’s disclosure controls and procedures with respect to the Fund, as defined under Exchange Act Rule 13a-15(e) as of June …

• There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures.

• There were no changes in the Trust’s and the Fund’s internal control over financial reporting that occurred during the quarter covered by this report that have materially affected, or are reasonably likely to materially affect, the Trust’s and/or the Fund’s internal control over financial reporting.

Text removed vs the prior filing · source: 10-Q · 2026-02-17

• The duly authorized officers of the Sponsor, performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, have evaluated the effectiveness of the Trust’s disclosure controls and procedures, and have c…

• The duly authorized officers of the Sponsor, performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, have evaluated the effectiveness of the Fund’s disclosure controls and procedures, and have co…

• There were no changes in the Trust’s and the Fund’s internal control over financial reporting that occurred during the fiscal quarter covered by this report that have materially affected, or are reasonably likely to materially affect, the Trust’s and/or the Fund’s internal control over financial rep…

• Each of the Sarbanes-Oxley certifications included as exhibits to this filing apply with respect to both the operations of both the Fund, as the sole series of the Trust, and the Trust as registrant.